IRIS
GAUDIO, AGOSTINO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 3.955
EU - Europa 2.093
AS - Asia 1.676
AF - Africa 275
SA - Sud America 246
Continente sconosciuto - Info sul continente non disponibili 9
OC - Oceania 1
Totale 8.255
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 3.786
SG - Singapore 866
IT - Italia 579
IE - Irlanda 553
CN - Cina 525
UA - Ucraina 490
BR - Brasile 233
CI - Costa d'Avorio 209
IN - India 187
CA - Canada 158
RU - Federazione Russa 133
SE - Svezia 78
DE - Germania 74
FR - Francia 53
SN - Senegal 33
GB - Regno Unito 29
KR - Corea 22
CH - Svizzera 20
NG - Nigeria 16
FI - Finlandia 15
UZ - Uzbekistan 14
NL - Olanda 13
GR - Grecia 12
VN - Vietnam 11
HK - Hong Kong 10
EU - Europa 8
AT - Austria 7
ZA - Sudafrica 7
BD - Bangladesh 6
IQ - Iraq 6
PL - Polonia 6
AE - Emirati Arabi Uniti 5
HU - Ungheria 5
JP - Giappone 5
MX - Messico 5
TR - Turchia 5
AR - Argentina 4
BG - Bulgaria 4
CZ - Repubblica Ceca 4
LB - Libano 4
MA - Marocco 4
RS - Serbia 4
EC - Ecuador 3
KE - Kenya 3
PY - Paraguay 3
AL - Albania 2
CR - Costa Rica 2
DK - Danimarca 2
ES - Italia 2
HR - Croazia 2
KZ - Kazakistan 2
LT - Lituania 2
SA - Arabia Saudita 2
UY - Uruguay 2
A1 - Anonimo 1
AU - Australia 1
AZ - Azerbaigian 1
BE - Belgio 1
BY - Bielorussia 1
CO - Colombia 1
DZ - Algeria 1
ET - Etiopia 1
GT - Guatemala 1
HN - Honduras 1
ID - Indonesia 1
IL - Israele 1
JM - Giamaica 1
JO - Giordania 1
LK - Sri Lanka 1
MK - Macedonia 1
PK - Pakistan 1
SK - Slovacchia (Repubblica Slovacca) 1
TN - Tunisia 1
TT - Trinidad e Tobago 1
Totale 8.255
Salva come PNG Salva come JPEG
Città #
Santa Clara 828
Dublin 553
Chandler 512
Singapore 510
Jacksonville 406
Boardman 245
Abidjan 209
Chicago 191
Cambridge 154
Lawrence 154
Kochi 148
Andover 147
Nanjing 144
Catania 125
Toronto 110
Ashburn 88
Des Moines 74
Wilmington 74
San Mateo 63
Ottawa 46
Saint Petersburg 40
Beijing 39
Civitanova Marche 36
Nanchang 36
Shenyang 36
Hebei 35
Dakar 33
Jiaxing 31
Palermo 29
Bremen 27
Hefei 26
Seoul 22
Changsha 21
Milan 21
Modica 21
Tianjin 19
Munich 18
Abuja 16
Padova 16
Seattle 16
Rome 15
Hangzhou 13
Pune 13
Houston 12
The Dalles 12
Washington 12
Civitavecchia 11
Los Angeles 11
Nocera Inferiore 11
Norwalk 11
Falls Church 10
Moscow 10
New York 10
São Paulo 10
Mascalucia 9
Messina 9
Ann Arbor 8
Brasília 8
Council Bluffs 8
Dong Ket 8
Lappeenranta 8
Redwood City 8
Rio de Janeiro 8
Frankfurt am Main 7
Belo Horizonte 6
Caltanissetta 6
Hong Kong 6
Ningbo 6
Budapest 5
Campinas 5
Casalecchio di Reno 5
Dallas 5
Frankfurt Am Main 5
Giarre 5
Jinan 5
Lausanne 5
Redmond 5
Salvador 5
Taizhou 5
Tokyo 5
Zhengzhou 5
Boston 4
Cesa 4
Changchun 4
Chennai 4
Cologne 4
Columbus 4
Den Haag 4
Fairfield 4
Osasco 4
Phoenix 4
Trecastagni 4
Turku 4
Uberlândia 4
West Jordan 4
Avola 3
Baghdad 3
Bernalda 3
Cape Town 3
Charlotte 3
Totale 5.721
Salva come PNG Salva come JPEG
Nome #
Anxiety, depression, chronic inflammation and aortic stiffness in Crohn’s disease: the brain-gut-vascular axis 111
A rare cause of leg pain 100
Co-Occurrence of Interleukin-6 Receptor Asp358Ala Variant and High Plasma Levels of IL-6: An Evidence of IL-6 Trans-Signaling Activation in Deep Vein Thrombosis (DVT) Patients 86
Venous thromboembolism in hospital emergency room. A retrospective study on climatic effect 85
Pulse wave velocity differs between ulcerative colitis and chronic kidney disease 83
A systematic review of arterial stiffness, wave reflection and air pollution 83
Adrenal effects of teriparatide in the treatment of severe postmenopausal osteoporosis 82
Dehydroepiandrosterone (DHEA) replacement therapy in elderly men with osteoporosis 81
Augmentation index is increased in patients with inflammatory bowel disease, a meta-analysis 81
Deep vein thrombosis related to environment (Review) 77
Bone health assessment by quantitative ultrasound and dual-energy x-ray absorptiometry in postmenopausal women with breast cancer receiving aromatase inhibitors 75
Anticoagulants and osteoporosis 75
Antihypertensive treatment changes and related clinical outcomes in older hospitalized patients 74
Riduzione della densità minerale ossea volumetrica (pQCT) in pazienti con epatopatia cronica HCV-correlata: confronto con la misurazione DEXA 74
Correlation between family history of hypertension and haemostatic disorders 72
Oxidative stress in peripheral arterial disease (PAD) mechanism and biomarkers 72
Melorheostosis and Osteopoikilosis Clinical and Molecular Description of an Italian Case Series 72
Bisphosphonates in the treatment of thalassemia-induced osteoporosis 70
Effects of the phytoestrogen genistein on some predictors of cardiovascular risk in osteopenic, postmenopausal women: a 2-years randomized, double-blind, placebo-controlled study 70
Pain in Osteoporosis: From Pathophysiology to Therapeutic Approach 70
Vascular dysfunction in Cardiorenal Syndrome type 4 70
Platelet-Derived Microparticles (MPs) and Thrombin Generation Velocity in Deep Vein Thrombosis (DVT): Results of a Case–Control Study 70
Donne in post-menopausa in trattamento farmacologico per la prevenzione primaria delle fratture osteoporotiche: primi dati di uno studio pilota su aderenza e persistenza alla terapia 69
The association between carotid or femoral atherosclerosis and low bone mass in postmenopausal women referred for osteoporosis screening. Does osteoprotegerin play a role? 69
Alterazioni emostatiche in pazienti con arteriopatia obliterante periferica con e senza diabete 68
Effetti del raloxifene sulla densità del parenchima mammario 68
A suspicious fracture 68
COVID-19-related retinal microvasculopathy and systemic implications in patients with severe disease: results from the Methuselah study 67
Bisphosphonates in the treatment of thalassemia-associated osteoporosis 67
Review: UPDATE sul metabolismo del magnesio 67
Reduction of volumetric bone mineral density in postmenopausal women with HCV-correlated chronic liver disease: a peripheral quantitative computed tomogtraphy (pQCT) study 67
Paget's bone disease is not always the culprit 66
Metabolic effects of dehydroepiandrosterone replacement therapy in postmenopausal women 66
Vitamin D levels are reduced at the time of hospital admission in sicilian SARS-CoV-2-positive patients 66
Paget's Disease of Bone and Cardiovascular Risk: a Pilot Study 66
Decreased bone cortical density at the forearm in subjects with subclinical peripheral arterial disease 65
Raloxifene e rischio cardiovascolare 65
Apparato locomotore 63
Osteoporosis and beta-thalassemia major: Role of the IGF-I/IGFBP-III axis 62
Biphosphonates prevent bone loss in thalassemia major patients 62
A strange case of dyspnoea 62
Heredity of the haemostatic disorders in non insulin dependent diabetes (NIDDM) 61
Randomized, double-blind, placebo-controlled study on effects of raloxifene and hormone replacement therapy on plasma NO concentrations, endothelin-1 levels, and endothelium-dependent vasodilation in postmenopausal women 61
More is not better 61
Pathogenesis of Thalassemia Major-associated Osteoporosis: A Review with Insights from Clinical Experience 61
Bone islands. 61
It Is Time for a Routine Measurement of Aortic Stiffness in Inflammatory Bowel Disease 60
Il neridronato previene il bone loss durante la terapia antiandrogena per il cancro prostatico 60
Anxiety levels predict fracture risk in postmenopausal women assessed for osteoporosis 60
Peripheral artery disease and osteoporosis: Not only age-related (Review) 60
Vascular dysfunction of COVID-19 is partially reverted in the long-term 60
Effects of genistein and hormone-replacement therapy on bone loss in early postmenopausal women: A randomized double-blind placebo-controlled study 59
The relationship between inhibitors of the Wnt signaling pathway (sclerostin and Dickkopf-1) and carotid intima-media thickness in postmenopausal women with type 2 diabetes mellitus 59
I bifosfonati prevengono la perdita d'osso nei pazienti thalassemici 59
Effects of long-lasting raloxifene treatment on serum prolactin and gonadotropin levels in postmenopausal women 58
Preventing bone loss during androgen deprivation therapy for prostate cancer: Early experience with neridronate 58
When the FRAX® test is applied to controlled clinical trials 58
Long-term hemostatic effects of cholesterol-lowering therapy with atorvastatin 58
Inter-Relationship between Platelet-Derived Microparticles and Oxidative Stress in Patients with Venous Thromboembolism 58
Bone health in Duchenne muscular dystrophy: clinical and biochemical correlates 58
Osteoprotegerina ed osteoporosi nei thalassemici 57
The "lively" cytokines network in beta-Thalassemia Major-related osteoporosis 56
Effects of a long-term treatment with raloxifene on insulin sensitivity in postmenopausal women 56
Ridotta risposta terapeutica all' alendronato in pazienti depresse affette da osteoporosi 56
Effetti del raloxifene sulla secrezione ipofisaria 56
Effetti della somministrazione di EPO sul metabolismo osseo nel ratto 56
Cortisol Secretion, Sensitivity, and Activity Are Associated With Hypertension in Postmenopausal Eucortisolemic Women 56
Insights from experiences on antiplatelet drugs in stroke prevention: A review 56
Reply to Ialongo et al. Vitamin D, SARS-CoV-2 and causal associations in transversal studies: The time-series analysis to reveal potential confounders. comment on “gaudio et al. vitamin d levels are reduced at the time of hospital admission in sicilian SARS-CoV-2-positive patients. Int. j. environ. res. public health 2021, 18, 3491” 56
Successful neridronate therapy in pregnancy-associated osteoporosis 55
Raloxifene and pituitary secretion in post-menopausal women 55
Hemostatic changes in vasculitides 54
Hemostatic effects of diets containing olive or soy oil in hypertensive patients 54
Livelli sierici di osteoprotegerina e markers del turnover osseo durante il trattamento con raloxifene: dati preliminari 54
Riduzione della densità minerale volumetrica in pazienti con epatopatia cronica HCV-correlata: confronto con la misurazione DEXA 54
Livelli circolanti di citochine osteotrope e rimodellamento osseo nei pazienti thalassemici 54
What changed in the Italian internal medicine and geriatric wards during the lockdown 54
Underdiagnosis and undertreatment of osteoporotic patients admitted in internal medicine wards in Italy between 2010 and 2016 (the REPOSI Register) 54
Effects of agonistic physical activity on the activation of WNT/beta-catenin signaling 53
Sclerostin is a possible candidate marker of arterial stiffness: Results from a cohort study in Catania 53
Response to Letter to the Editor: "Methodological Issues Regarding Cortisol Secretion, Sensitivity, and Activity are Associated With Hypertension in Postmenopausal Eucortisolemic Women" 53
Effects of administration of Dehydroepiandrosterone (DHEA) on male senile osteoporosis 52
Relationships between osteoprotegerin, receptor activator of the nuclear factor kB ligand and serum levels and carotid intima-media thickness in patients with type 2 diabetes mellitus. 50
Effetti del Raloxifene sulla secrezione ipofisaria in post-menopausa 50
Effects of strontium ranelate on bone mass and bone turnover in women with thalassemia major-related osteoporosis 50
Neridronate in the treatment of thalassemia-induced osteoporosis 50
Three-year effectiveness of intravenous pamidronate versus pamidronate plus slow-release sodium fluoride for postmenopausal osteoporosis 49
Ultrasonografia ossea e DEXA nella valutazione dell' osteoporosi secondaria ad insufficienza renale cronica in trattamento sostitutivo emodialitico 49
Effetti del fitoestrogeno genisteina sul metabolismo osseo in donne in postmenopausa:COFIN 2002 dati a 12 mesi 49
Role of genetic pattern on bone mineral density in thalassemic patients 49
Rete Osteoporosi Sicilia (Sicilian Osteoporosis Network): an IT platform for the improvement of diagnosis and treatment of osteoporosis in Sicily. 49
Hematological Diseases and Osteoporosis 49
Anxiety levels predict bone mineral density in postmenopausal women undergoing oral bisphosphonates: A two-year follow-up 49
Erythropoietin: A novel DABA? 48
Handgrip strength to discriminate high fracture risk in type 2 diabetes mellitus patients. 48
Sclerostin Levels Associated with Inhibition of the Wnt/β-Catenin Signaling and Reduced Bone Turnover in Type 2 Diabetes Mellitus 47
Eritropoietina: un nuovo D.A.B.A.? 47
Hemostasis and fibrinolysis factors in first-degree relatives of patients with type 2 diabetes without hypertension 47
Osteoprotegerin and RANKL in the pathogenesis of thalassemia-induced osteoporosis: new pieces of the puzzle 47
Neridronate in the treatment of thalassemia-induced osteoporosis 46
Totale 6.193
Salva come PNG Salva come JPEG
Categoria #
all - tutte 34.501
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 34.501
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021892 33 82 90 22 245 38 100 8 74 49 104 47
2021/20221.117 112 156 14 20 184 15 162 43 102 2 59 248
2022/20231.705 164 66 22 143 189 308 7 261 418 27 46 54
2023/2024802 38 141 49 38 38 177 6 55 2 30 130 98
2024/20253.002 18 428 151 96 673 380 55 124 156 346 341 234
2025/20269 9 0 0 0 0 0 0 0 0 0 0 0
Totale 8.595